News

New Medication Release of Symbravo
New Medication Release of Symbravo

The FDA recently approved Symbravo® (meloxicam/rizatriptan) for the acute treatment of migraine with or without…

Oct 08, 2025
New Medication Release of Tonmya
New Medication Release of Tonmya

The FDA has approved Tonmya (cyclobenzaprine HCl sublingual tablet) for the treatment of fibromyalgia in…

Sep 15, 2025
Generic Release Of Dexilant Is Now Available

The generic formulation of Dexilant, Dexlansoprazole, has been recently released. Dexlansoprazole is a Proton Pump…

Jan 14, 2022
Generic Release of Narcan Nasal Spray

Sanchez Pharmaceuticals announce the launch of its authorized generic Narcan (naloxone hydrochloride) Nasal Spray 4mg….

Dec 29, 2021
New Medication Release of Semglee

Semglee (insulin glargine-yfgn) co-developed by Viatris and Biocon Biologics, is the first interchangeable biosimilar product…

Dec 16, 2021
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Discover our latest educational white paper on the crucial role of Causation Letters in workers’ comp claims.

In workers’ compensation, the ability to establish a clear connection between an injury or illness and the workplace is fundamental to the success of a claim. Causation letters serve as the vital link that connects medical evidence to legal standards, ensuring that the injury is recognized as work-related. Explore the full report for in-depth insights. Click below for more details!

Download Now
Injury, Illness and Work-Related Activity: The Crucial Role of Causation Letters in Workers’ Compensation Claims